ETF Home ETF List Shorted Stocks Home About

ETF Holdings Breakdown of NTRA

Stock NameNatera Inc
TickerNTRA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6323071042

NTRA institutional holdings

The adjusted close for NTRA on 2025-12-09 was 235.53

The following institutional investment holdings of NTRA have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2025-12-09 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 29,975USD 7,060,012 235.53  
2025-12-09 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 21,633USD 5,095,220 235.53  
2025-12-09 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 3,175USD 747,808 235.53  
2025-12-09 IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc)) 11,786USD 2,775,957 -1.5% 235.53  
2025-12-09 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 33,514USD 7,893,552 235.53  
2025-12-09 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 4,834 0.4%USD 1,138,552 -1.1% 235.53  
2025-12-09 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 41,597 0.1%USD 9,797,341 -1.4% 235.53  
2025-12-09 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 2,089USD 492,022 235.53  
2025-12-09 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 194,024USD 45,698,473 235.53  
2025-12-09 IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc) 196USD 46,164 -1.5% 235.53  
2025-12-09 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 13,011USD 3,064,481 235.53  
2025-12-09 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 2,574USD 606,254 -1.5% 235.53  
2025-12-09 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 750USD 132,843 -1.4% 177.12 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 235.53 not 177.12. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B42YS929 incorrectly reporting value of holding as USD actually is reported in GBP
2025-12-09 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 194,024USD 45,698,473 235.53  
2025-12-09 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 6,440USD 1,516,813 -1.5% 235.53  
2025-12-09 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 4,685USD 1,103,458 -1.5% 235.53  
2025-12-09 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 194,024USD 45,698,473 235.53  
2025-12-09 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 41,597USD 9,797,341 235.53  
2025-12-09 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 10,208USD 2,404,290 235.53  
2025-12-09 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 10,208USD 2,404,290 -1.5% 235.53  
2025-12-09 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 2,878USD 677,855 235.53  
2025-12-09 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 15,536USD 3,659,194 235.53  
2025-12-09 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 3,175USD 747,808 -1.5% 235.53  
2025-12-09 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 194,024USD 45,698,473 -1.5% 235.53  
2025-12-09 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 33,514USD 7,893,552 235.53  
2025-12-09 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 2,293USD 540,070 235.53  
2025-12-09 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 92,010USD 21,671,115 235.53  
2025-12-08 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 9,192USD 1,890,903 -2.1% 205.71 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 235.53 not 205.71. May be due to incorrect reporting of currency . Could be EUR or USD insteadIE00B441G979 incorrectly reporting value of holding as USD actually is reported in EUR
2025-12-08 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 29,975USD 7,168,222 -2.3% 239.14 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 235.53 not 239.14. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-12-08 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 2,878 0.2%USD 688,245 -1.0% 239.14 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 235.53 not 239.14. May be due to incorrect reporting of currency . Could be EUR or USD instead 
2025-12-05 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 41,541 0.0%USD 10,158,852 1.0% 244.55 Warning! :Potential incorrect reporting.Incorrect share price reported. Should be 235.53 not 244.55. May be due to incorrect reporting of currency . Could be EUR or USD instead 
Total =1,247,360 USD 293,966,106
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with NTRA

Financial Contrast: Natera (NASDAQ:NTRA) & Oncology Institute (NASDAQ:TOI)
Natera (NASDAQ:NTRA – Get Free Report) and Oncology Institute (NASDAQ:TOI – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Institutional and Insider Ownership 99.9% of Natera shares are […] - 2025-09-17 03:14:43
Natera (NASDAQ:NTRA) Stock Acquired Rep. Josh Gottheimer
Representative Josh Gottheimer (D-New Jersey) recently bought shares of Natera, Inc. (NASDAQ:NTRA). In a filing disclosed on September 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in Natera stock on August 22nd. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account. Representative Josh Gottheimer also […] - 2025-09-09 03:10:46
Natera, Inc. (NASDAQ:NTRA) Receives $194.00 Average Price Target from Brokerages
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has earned a consensus rating of “Buy” from the eighteen ratings firms that are covering the firm, Marketbeat Ratings reports. Seventeen research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target […] - 2025-09-08 03:08:53
Rowan Chapman Sells 2,750 Shares of Natera (NASDAQ:NTRA) Stock
Natera, Inc. (NASDAQ:NTRA – Get Free Report) Director Rowan Chapman sold 2,750 shares of the firm’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $166.99, for a total value of $459,222.50. Following the completion of the sale, the director directly owned 6,015 shares in […] - 2025-09-04 05:23:03
Financial Survey: Natera (NASDAQ:NTRA) vs. Solventum (NYSE:SOLV)
Natera (NASDAQ:NTRA – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Analyst Recommendations This is a summary of current ratings […] - 2025-08-15 05:40:53
Natera, Inc. (NASDAQ:NTRA) Receives $192.53 Consensus Target Price from Analysts
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has earned an average recommendation of “Buy” from the seventeen ratings firms that are covering the company, MarketBeat reports. Sixteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts […] - 2025-08-14 03:07:06
Deutsche Bank AG Purchases 160,243 Shares of Natera, Inc. (NASDAQ:NTRA)
Deutsche Bank AG raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 185.8% in the first quarter, HoldingsChannel reports. The firm owned 246,482 shares of the medical research company’s stock after acquiring an additional 160,243 shares during the period. Deutsche Bank AG’s holdings in Natera were worth $34,855,000 as of its […] - 2025-08-13 05:24:57
Charles Schwab Investment Management Inc. Raises Holdings in Natera, Inc. (NASDAQ:NTRA)
Charles Schwab Investment Management Inc. boosted its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 4.4% in the 1st quarter, HoldingsChannel reports. The fund owned 905,676 shares of the medical research company’s stock after buying an additional 38,180 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Natera were worth […] - 2025-08-12 05:23:02
NTRA Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of Natera Inc (Symbol: NTRA) crossed above their 200 day moving average of $154.62, changing hands as high as $165.09 per share. Natera Inc shares are currently trading up about 11.7% on the day. The chart below shows the one year performance of NT - 2025-08-08 12:49:35
Harbour Investments Inc. Has $139,000 Stock Position in Natera, Inc. (NASDAQ:NTRA)
Harbour Investments Inc. raised its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 57.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 983 shares of the medical research company’s stock after buying an additional 359 shares […] - 2025-08-08 05:26:55
Natera, Inc. (NASDAQ:NTRA) Shares Purchased by HighPoint Advisor Group LLC
HighPoint Advisor Group LLC lifted its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 30.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,986 shares of the medical research company’s stock after purchasing an additional 468 shares during […] - 2025-07-24 08:19:53
Solomon Moshkevich Sells 1,649 Shares of Natera, Inc. (NASDAQ:NTRA) Stock
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Solomon Moshkevich sold 1,649 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $156.85, for a total transaction of $258,645.65. Following the completion of the sale, the insider owned 128,556 shares of the company’s stock, valued […] - 2025-07-24 06:20:52
Notable Two Hundred Day Moving Average Cross - NTRA
In trading on Tuesday, shares of Natera Inc (Symbol: NTRA) crossed below their 200 day moving average of $153.49, changing hands as low as $152.02 per share. Natera Inc shares are currently trading off about 3.6% on the day. The chart below shows the one year performance of NT - 2025-07-15 12:33:44
Cerity Partners LLC Has $12.11 Million Stock Position in Natera, Inc. (NASDAQ:NTRA)
Cerity Partners LLC raised its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 7.3% in the first quarter, HoldingsChannel.com reports. The firm owned 85,645 shares of the medical research company’s stock after purchasing an additional 5,863 shares during the quarter. Cerity Partners LLC’s holdings in Natera were worth $12,111,000 at the end […] - 2025-07-15 07:46:49
Oppenheimer Asset Management Inc. Trims Holdings in Natera, Inc. (NASDAQ:NTRA)
Oppenheimer Asset Management Inc. decreased its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 12.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,744 shares of the medical research company’s stock after selling 2,515 shares during the period. […] - 2025-06-27 05:38:46
ORG Partners LLC Purchases Shares of 233 Natera, Inc. (NASDAQ:NTRA)
ORG Partners LLC bought a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) during the first quarter, HoldingsChannel.com reports. The firm bought 233 shares of the medical research company’s stock, valued at approximately $32,000. A number of other institutional investors and hedge funds have also recently made changes to their positions in […] - 2025-06-23 05:08:59
Exchange Traded Concepts LLC Buys 871 Shares of Natera, Inc. (NASDAQ:NTRA)
Exchange Traded Concepts LLC increased its holdings in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 15.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,458 shares of the medical research company’s stock after buying an additional 871 shares during […] - 2025-06-20 05:49:06
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Fifth Third Bancorp
Fifth Third Bancorp cut its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 81.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,064 shares of the medical research company’s stock after selling 4,565 shares during the period. Fifth Third Bancorp’s holdings […] - 2025-06-20 04:46:49
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Wedmont Private Capital Buys Shares of 1,506 Natera, Inc. (NASDAQ:NTRA)
Wedmont Private Capital purchased a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,506 shares of the medical research company’s stock, valued at approximately $223,000. A number of other institutional investors have also […] - 2025-06-12 05:35:00
GAMMA Investing LLC Increases Stock Holdings in Natera, Inc. (NASDAQ:NTRA)
GAMMA Investing LLC boosted its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 18,607.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 119,916 shares of the medical research company’s stock after purchasing an additional 119,275 shares during the quarter. […] - 2025-06-06 05:48:57
Mackenzie Financial Corp Purchases 1,092 Shares of Natera, Inc. (NASDAQ:NTRA)
Mackenzie Financial Corp lifted its position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 33.9% during the fourth quarter, HoldingsChannel reports. The firm owned 4,317 shares of the medical research company’s stock after buying an additional 1,092 shares during the quarter. Mackenzie Financial Corp’s holdings in Natera were worth $683,000 at the end […] - 2025-06-02 05:53:03
Notable ETF Outflow Detected - XBI, EXAS, NBIX, NTRA
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $257.5 million dollar outflow -- that's a 5.2% decrease week over week - 2025-05-30 14:40:38
Quantinno Capital Management LP Takes $373,000 Position in Natera, Inc. (NASDAQ:NTRA)
Quantinno Capital Management LP bought a new position in Natera, Inc. (NASDAQ:NTRA – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 2,356 shares of the medical research company’s stock, valued at approximately $373,000. Other institutional investors also recently bought and sold shares of the company. […] - 2025-05-26 04:57:03
Lazard Asset Management LLC Buys 551 Shares of Natera, Inc. (NASDAQ:NTRA)
Lazard Asset Management LLC raised its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 22.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,052 shares of the medical research company’s stock after acquiring an additional 551 shares during the period. Lazard Asset […] - 2025-05-22 05:48:58
Focus Partners Wealth Purchases 1,442 Shares of Natera, Inc. (NASDAQ:NTRA)
Focus Partners Wealth raised its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 35.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,519 shares of the medical research company’s stock after purchasing an additional 1,442 shares during the period. […] - 2025-05-19 05:20:56
Cetera Investment Advisers Cuts Stake in Natera, Inc. (NASDAQ:NTRA)
Cetera Investment Advisers reduced its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 8.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 13,145 shares of the medical research company’s stock after selling 1,176 shares during the period. Cetera Investment Advisers’ holdings in Natera were worth […] - 2025-05-19 04:38:49
XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $288.7 million dollar outflow -- that's a 5.9% decrease week over week - 2025-05-09 11:52:51
Townsquare Capital LLC Acquires New Position in Natera, Inc. (NASDAQ:NTRA)
Townsquare Capital LLC bought a new position in Natera, Inc. (NASDAQ:NTRA – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor bought 1,568 shares of the medical research company’s stock, valued at approximately $248,000. Other hedge funds and other institutional investors also recently bought and sold shares of the company. Blue Trust […] - 2025-04-23 06:58:51
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. lowered its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 21.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 31,175 shares of the medical research company’s stock after selling 8,390 shares during the quarter. Russell Investments Group Ltd.’s holdings in Natera […] - 2025-04-15 07:53:06

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Copyright Market Footprint Ltd. Privacy Policy